First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma »
Posted by: dirtyfratboy 2 months, 1 week agoInternational research involving the University Hospital of the University of Navarra, together with other hospitals in Spain, has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas (liver tumours) to live 40% more on average compared to those not taking the drug.
Read Full Story at sciencedaily.com
Submitted By:
dirtyfratboy
Hey all, I'm Henry. I'm a student right now and I'll be majoring in Business at the University of Illinois Urbana-Champaign. During ...
Also submitted:
- 1.0 - Grays Reef National Marine Sanctuary In Fair Condition, Facing Emerging Threats
- 1.0 - Shot In The Arm For Sumatran Elephants And Tigers
- 1.0 - Incidence Of Intestinal Parasite Coccidia Is Increasing In Broilers
- 1.0 - No More Big Stink: Scent Lures Mosquitoes, But Humans Can't Smell It
Related Articles:
Why not submit a story?
Also Propping This Article
Groups Watching This
No groups are watching this story. Why not share it with your group?
